制备了具有醚官能团的烷基吡啶鎓(10a,R = Me 和 10b,R = Et)和四烷基鏻(19)离子液体,并评估它们作为格氏反应的溶剂和共溶剂。有趣的是,当在吡啶 IL 10a、b 中进行反应时,在没有醚共溶剂的情况下,将起始醛还原为相应的伯醇是有利的途径。然而,在乙醚作为共溶剂存在的情况下,在鏻 IL 19 中的相同反应以良好的产率提供了预期的格氏产品。
[EN] AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON<br/>[FR] COMPOSÉS D'AMINO-PYRIMIDINE EN TANT QU'INHIBITEURS DE TBKL ET OU D'IKK EPSILON
申请人:MYREXIS INC
公开号:WO2011046970A1
公开(公告)日:2011-04-21
The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).
NOVEL COMPOUNDS AS MODULATORS OF GLUCOCORTICOID RECEPTORS
申请人:Thombare Pravin S.
公开号:US20120220590A1
公开(公告)日:2012-08-30
Compounds of formula (I) and pharmaceutical compositions containing them are described. The use of the compounds and compositions are also described.
描述了化合物(I)的结构和含有它们的药物组合物。还描述了这些化合物和组合物的用途。
[EN] INDOLINE AND TETRAHYDROQUINOLINE SULFONYL INHIBITORS OF DIMETALLOENZYMES AND USE OF THE SAME<br/>[FR] INHIBITEURS DE TYPE INDOLINE ET TÉTRAHYDROQUINOLINE SULFONYLE DES DIMÉTALLO-ENZYMES ET LEUR UTILISATION
申请人:UNIV LOYOLA CHICAGO
公开号:WO2017011408A1
公开(公告)日:2017-01-19
Indoline and tetrahydroquinoline sulfonyl compounds that can inhibit DapE and/or bacterial metallo-β-lactamases ("MBLs"), such as NDM-1 are disclosed. Also disclosed are methods of treating an individual suffering from a bacterial infection using the compounds disclosed herein.
Described herein are pyrrolo[2,3-d]pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing these compounds, and methods for their preparation.